IRIS
LEONI, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.129
EU - Europa 6.348
AS - Asia 2.560
SA - Sud America 442
AF - Africa 231
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 7
Totale 18.742
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.091
UA - Ucraina 1.389
SE - Svezia 833
IT - Italia 754
IE - Irlanda 705
RU - Federazione Russa 691
SG - Singapore 678
DE - Germania 659
TR - Turchia 656
DK - Danimarca 541
HK - Hong Kong 441
BR - Brasile 415
CN - Cina 385
FI - Finlandia 327
KR - Corea 290
GB - Regno Unito 190
FR - Francia 167
CI - Costa d'Avorio 113
MA - Marocco 105
IN - India 44
BE - Belgio 27
EU - Europa 25
CA - Canada 23
MX - Messico 11
NL - Olanda 10
CZ - Repubblica Ceca 9
ES - Italia 9
IQ - Iraq 9
JP - Giappone 9
RO - Romania 9
AT - Austria 8
BD - Bangladesh 8
UZ - Uzbekistan 8
AR - Argentina 6
AU - Australia 6
CO - Colombia 6
EC - Ecuador 6
PK - Pakistan 6
PL - Polonia 5
VE - Venezuela 5
ZA - Sudafrica 5
GR - Grecia 4
AZ - Azerbaigian 3
BZ - Belize 3
CH - Svizzera 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
IR - Iran 2
NP - Nepal 2
OM - Oman 2
TH - Thailandia 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
KG - Kirghizistan 1
LK - Sri Lanka 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
VN - Vietnam 1
Totale 18.742
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.423
Chandler 1.049
Fairfield 779
Boardman 704
Dublin 703
Wilmington 473
Ashburn 472
Hong Kong 439
Woodbridge 350
Singapore 307
San Mateo 291
Houston 288
Lawrence 286
New York 286
Princeton 286
Seattle 281
Des Moines 233
Cambridge 212
Ann Arbor 189
Centro 166
Moscow 154
San Diego 116
Abidjan 113
Redmond 93
The Dalles 80
Porto 79
Beijing 73
Turin 53
Shanghai 42
Milan 39
Los Angeles 38
Guangzhou 32
Helsinki 30
Pune 29
London 28
São Paulo 28
Norwalk 27
Pianella 27
Brussels 25
Marche 23
Dallas 21
Izmir 19
Auburn Hills 16
Munich 16
Civitanova Marche 15
Wuhan 15
Rome 13
Washington 13
Turku 12
Ancona 10
Jinhua 10
Prescot 10
Venice 10
Wuxi 10
Curitiba 9
Falls Church 9
Olomouc 9
Rio de Janeiro 9
Belo Horizonte 8
New Bedfont 8
Nuremberg 8
Tashkent 8
Boston 7
Fayetteville 7
Istanbul 7
Brasília 6
Catania 6
Hyderabad 6
Jesi 6
Jiaxing 6
Kilburn 6
Ottawa 6
Shenzhen 6
Tokyo 6
Campinas 5
Chiswick 5
Frankfurt am Main 5
Hangzhou 5
Leeds 5
Mexico City 5
Phoenix 5
Porto Alegre 5
Quanzhou 5
San Francisco 5
Santa Clara 5
Sydney 5
Vienna 5
Baghdad 4
Bari 4
Bristol 4
Chicago 4
Corato 4
Franca 4
Joinville 4
Jundiaí 4
Manaus 4
Montréal 4
Naples 4
Recife 4
Ribeirão Preto 4
Totale 10.796
Salva come PNG Salva come JPEG
Nome #
Human white adipocytes convert into “rainbow” adipocytes in vitro 206
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 145
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 143
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 131
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 128
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 117
Glial-like differentiation potential of human mature adipocytes 117
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme 114
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 112
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 112
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 112
Primary B-cell lymphoblastic lymphoma of the testis 111
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 108
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 107
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 107
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 104
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 103
Meningioma-like cerebral relapse of Hodgkin's disease. 103
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 102
Plasticity of human dedifferentiated adipocytes toward endothelial cells 101
Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: The role of the WHO histological diagnosis 101
Biosafety evidence for human dedifferentiated adipocytes 100
Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides. 100
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 98
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 98
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 98
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 97
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 96
Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma. 96
Ematuria ed emospermia ricorrenti: uniche manifestazioni di malattia di von Willebrand di tipo I. First report 96
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 95
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 95
Severe diarrhoea During Campath-1H Treatment For Refractory Cutaneous T Cell Lymphoma 95
Diffuse large B-cell lymphoma with Homer-Wright rosettes, sinusoidal growth pattern, and CD30 expression: a possible overlapping between micovillous lymphomas and sinusal CD30-positive large B-cell lymphomas. 93
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 93
Molecular and functional characterization of human bone marrow adipocytes 92
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 91
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 91
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase 3 study 90
Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas 90
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 90
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS) 88
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 88
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report 88
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 88
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 88
Primary testicular lymphoblastic B lymphoma: ultrasonographic features and clinical implications 87
Bone marrow adipocytes support haematopoietic stem cell survival 87
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 86
Prognostic clinical, laboratoristic and molecular factors in mycosis fungoides 86
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 86
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 85
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 84
Immunostaining for nucleophosmin in bone marrow trephine biopsy specimens in acute myeloid leukemias 84
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 84
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 84
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 84
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 84
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 84
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 84
The value of PCR in the diagnosis and monitoring of early stage of mycosis fungoids treated with Interferon plus PUVA 84
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial 83
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 82
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 82
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 82
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 82
High remission rate in T-Cell prolymphocytic leukemia with Campath-1H 81
Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple mieloma 81
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow 81
A case of monoclonal gammopathy of undetermined significance (MGUS): type IgD-lambda. 81
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 81
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes 81
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 80
[Hodgkin's lymphoma and secondary leukemias]. 80
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 80
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies. 80
Risk assessment of patients with Hematologic malignancies who develop fever accompanied by pulmonary infiltrates. A historic cohort study. 79
Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. 79
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 79
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II stud 78
Clonal TCR gamma e TCR delta rearrangement in peripheral blood in MF/SS patients 78
Prospective multicentric Clinical trial on the use of Interferon-a plus PUVA in patients with early stage Mycosis Fungoides. 78
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 78
Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. 77
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 77
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 77
Central nervous system involvement is a negative prognostic factor in primary cutaneous B-cell lymphoma. 77
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 77
A circulating T cell clone in early Mycosis Fungoides is not a negative prognostic factor when the disease is treated by a combination of PUVA plus interferon alpha 76
Risk of non-Hodgkin lymphoma in celiac disease 76
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 76
Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. 76
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 76
TIME TO NEXT TREATMENT ANALYSIS FOR EARLY AND ADVANCED STAGES OF MYCOSIS FUNGOIDES/SEZARY SYNDROME TREATED WITH BEXAROTENE AND PUVA IN COMBINATION 76
CD8+ lymphocytes and CD1a+ dendritic cells in mycosis fungoides: correlation with epidermotropism, subepidermal lymphoid infiltrate, response to therapy and disease recurrence 75
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 75
Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry. 74
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study 74
Risk of Thromboembolic Events in ET and Early / Prefibrotic PMF: The Relevance of an Accurate Histological Diagnosis 73
Signet ring cells are not uncommon in cutaneous B-cell lymphoma and seem not to be associated with a specific clinical behaviour 73
Totale 9.142
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.724
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020429 0 0 0 0 0 0 0 0 0 0 84 345
2020/20213.524 145 386 545 38 471 193 358 162 426 266 388 146
2021/20222.187 99 620 23 176 16 79 99 171 115 178 158 453
2022/20233.296 343 373 278 258 254 492 1 172 864 19 178 64
2023/20241.955 350 49 102 341 334 369 27 46 5 38 20 274
2024/20253.245 429 424 172 48 169 78 486 113 868 285 173 0
Totale 19.103